At ASH 2025, iMMagine-1 data showed that anito-cel has a favorable and durable safety profile with low rates of severe CRS, neurotoxicity, and infections.
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Answering this ...
"I won't hold my breath, because most of my patients do relapse at some point, but I was really excited about this curve when I saw it." -- Krina Patel, MD, MSc, of MD Anderson Cancer Center in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback